Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
Marie Cambot/LinkedIn
Dec 18, 2025, 16:50

Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD

Marie Cambot, Co founder and CEO at INNOVHEM, reposted from INNOVHEM on LinkedIn:

”Many thanks to Dr. Anoosha Habibi for this important presentation and for using what we have developed at Innovhem, namely the quantification of the HbF/HbS ratio per cell, which allows us to provide the percentage of protected cells among the red blood cells of patients with sickle cell disease.”

Quoting INNOVHEM‘s post:

”We are delighted to share Dr. Anoosha Habibi’s work on the effect of iron deficiency on the efficacy of hydroxyurea treatment in sickle cell disease, presented at the ASH2025 conference!

These results highlight how our single-cell quantification of fetal hemoglobin can support therapeutic strategies and bring us closer to personalized care.

A big thank you to the entire team of UMGGR – GHU Henri Mondor, Pr Pablo Bartolucci MD PhD, Gonzalo De Luna, Vincent de Pierrefeu, Elena Properzi, Fatima Bensiradj, Geoffroy Volle, Anais Bourguignon d’Herbigny, Yosr Zaouali, Stephane Moutereau, Nicolas Hebert, Frédéric Galacteros and collaborators who made this possible.

Innovation in hematology is a collective effort, and we’re proud to contribute to advancing knowledge for better patient lives.

Curious to learn more?

Let’s connect and discuss how these results could impact future treatments.”

Marie Cambot on Innovhem's Quantification of The HbF/HbS Ratio for SCD

All from ASH25 featured in Hemostasis Today.

Anoosha Habibi ASH2025 ASH25 HbF HbS Health Hematology Hemostasis Hemostasis Today Hydroxyurea INNOVHEM Marie Cambot Medicine RBCs SCD Sickle Cell Disease thrombosis
NewsFeed